4.2 Review

Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas

Journal

ENDOCRINE JOURNAL
Volume 63, Issue 3, Pages 213-219

Publisher

JAPAN ENDOCRINE SOC
DOI: 10.1507/endocrj.EJ15-0734

Keywords

Cas9; CRISPR; Embryonic stem cell; iPS cell; Knockout mice

Ask authors/readers for more resources

Clustered regularly at interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) nucleases, so-called CRISPR/Cas, was recently developed as an epoch-making genome engineering technology. This system only requires Cas9 nuclease and single-guide RNA complementary to a target locus. CRISPR/Cas enables the generation of knockout cells and animals in a single step. This system can also be used to generate multiple mutations and knockin in a single step, which is not possible using other methods. In this review, we provide an overview of genome editing by CRISPR/Cas in pluripotent stem cells and mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available